BREAKING NEWS!: FDA Approves Apalutamide (Erleada) for the treatment of metastatic hormone-sensitive prostate cancer. Read More.
Go here to learn more or to get a mailed copy.
Home » Bio » Board Members
Executive Director, Programs
President, Samaritan Health Initiatives, Inc.
Former Commissioner, Food and Drug Administration
Former Director, National Cancer Institute
Senior Fellow, Milken Institute